Use this dropdown to select your preferred language.
NTT DATA is a trusted global innovator of IT and business services headquartered in Tokyo. We help clients transform through consulting, industry solutions, business process services, IT modernization and managed services. NTT DATA enables clients and society to move confidently into the digital future. We are committed to our clients’ long-term success and combine global reach with local client attention to serve them in over 50 countries.
We support every client in their digital transformation with a comprehensive portfolio of consulting, technology, applications, infrastructure, and BPO services. We foster an open and collaborative community, driven by shared values, that expands into a global talent network. Together, we amplify capabilities and knowledge to respond with agility to today’s challenges and intelligently anticipate tomorrow’s opportunities.
勃林格殷格翰是全球领先的生物制药企业，布局人用药品、动物保健两大业务领域。公司研发投入位居行业前列，致力于研究突破性疗法，解决巨大未满足的医疗需求，从而帮助改善或延长生命。自1885年成立以来，勃林格殷格翰一直是独立的家族企业，始终着眼长远发展，将可持续发展理念贯穿全价值链。公司在全球有近5.45万名员工，服务逾130个市场，致力于打造一个更健康、更可持续、更公平的未来。勃林格殷格翰于1994年进入中国，总部位于上海，业务遍布全国，拥有约3,200名员工。公司致力于人用药品、动物保健、生物制药合同开发与生产三大业务，实现研发、生产、商业运营、外部创新合作的全价值链布局。中国是勃林格殷格翰的重点市场和创新高地之一，公司将中国患者的需求纳入全球研发策略，致力于把更多更好的创新产品更早地带给中国的患者，助力中国健康产业的高质量发展，全面改善人与动物的健康。
Boehringer Ingelheim trabaja en desarrollar terapias innovadoras que mejoren las vidas de humanos y animales. Cerca de 52.000 colaboradores en tres áreas de negocio – Salud Humana, Salud Animal y Fabricación por Contrato de Productos Biofarmacéuticos- y más de 130 mercados, crean valor a través de la innovación en áreas de grandes necesidades médicas insatisfechas como compañía independiente y familiar desde su fundación en 1885.
JTI is a dynamic organization of over 46,000 employees working across 70 countries. We are the leading tobacco company in Kazakhstan producing world-renowned brands at our factory in Almaty. Our head office here has a significant presence in some Central Asia and Mongolia countries as well.
JTI Kazakhstan holds Top Employer certification since 2014. This achievement showcases our commitment to the best-in-class people and culture practices.
We have been transforming lives in healthcare since 1885. Our 53,000 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.
We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.
At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company we focus on long term performance. We are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture.
Boehringer Ingelheim Middle East & North Africa
Pharmaceutical Company
please use the eps logo as the png logo is cropped and not full
Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date.
* The company description for this page is added by the organisation and is not written by Top Employers Institute.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
As a leading research-driven biopharmaceutical company Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. The Regional Center Vienna is responsible for the business in Austria and more than thirty countries in Central and Eastern Europe and Central Asia, as well as Switzerland and Israel and is also the group’s main cancer research site.